Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 266.20
+1.60 (0.60%)
Jun 30, 2026, 4:15 PM CET
Demant Market Cap
Demant has a market cap or net worth of 55.8 billion as of June 30, 2026. Its market cap has decreased by -7.56% in one year.
Market Cap
55.80B
Enterprise Value
75.54B
Revenue
22.97B
Ranking
n/a
PE Ratio
23.63
Stock Price
266.20
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 55.80B, an increase of 2,533.56%. That is a compound annual growth rate of 11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 55.80B | 21.73% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.41T |
| Genmab | 104.49B |
| Coloplast | 85.99B |
| ALK-Abelló | 55.61B |
| H. Lundbeck | 40.51B |
| Zealand Pharma | 20.00B |
| Ambu A/S | 16.08B |
| Bavarian Nordic | 13.69B |